{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:34Z","timestamp":1786119154572,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/gco.0b013e3282f1e7b6","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T20:45:32Z","timestamp":1236199532000},"page":"547-553","source":"Crossref","is-referenced-by-count":9,"title":["Recent advances in hormonal contraception"],"prefix":"10.1097","volume":"19","author":[{"given":"Risto","family":"Erkkola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl Med J"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptive","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"R6-8-20210129","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin\u2013aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09637480601137066","article-title":"Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism","volume":"23","author":"Batukan","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drosperinone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142 475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"R10-8-20210129","first-page":"1","article-title":"The pharmacological profile of dienogest","volume":"3","author":"Oettel","year":"1998","journal-title":"Eur J Contraception Reprod Healthcare"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archinte.167.3.282","article-title":"Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study","volume":"167","author":"van Vlijmen","year":"2007","journal-title":"Arch Intern Med"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bmj.2.6085.487","article-title":"Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen","volume":"2","author":"Loudon","year":"1977","journal-title":"BMJ"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(99)11159-0","article-title":"Nuisance or natural and healthy: should menstruation be optional for women?","volume":"355","author":"Thomas","year":"2000","journal-title":"Lancet"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajog.2005.12.045","article-title":"Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial","volume":"195","author":"Anderson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2005.06.068","article-title":"The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days","volume":"73","author":"Foidart","year":"2006","journal-title":"Contraception"},{"key":"R16-8-20210129","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"R18-8-20210129","first-page":"CD004695","article-title":"Continuous or extended cycle versus cyclic use of combined oral contraceptives for contraception.","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"R20-8-20210129","first-page":"799","article-title":"Efficacy and safety of a transdermal contraceptive system","volume":"98","author":"Smallwood","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"R22-8-20210129","first-page":"585","article-title":"Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring","volume":"100","author":"Dieben","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.contraception.2007.01.013","article-title":"The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trial","volume":"75","author":"Roumen","year":"2007","journal-title":"Contraception"},{"issue":"4 Suppl","key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ajog.2004.01.056","article-title":"New delivery systems in contraception: vaginal rings","volume":"190","author":"Johansson","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0001-6349.2005.00759.x","article-title":"Role of progestins in contraception","volume":"84","author":"Erkkola","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6 Suppl 1","key":"R26-8-20210129","first-page":"S1","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"R28-8-20210129","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/14.4.982","article-title":"Comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily","volume":"14","author":"Rice","year":"1999","journal-title":"Hum Reprod"},{"key":"R29-8-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1290.019","article-title":"Seventy-five microgram desogestrel minipill, a new perspective in estrogen free contraception","volume":"997","author":"Benagiano","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R30-8-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2004.07.016","article-title":"Maintenance of ovulation inhibition with 75 microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12 h delays in tablet intake","volume":"71","author":"Korver","year":"2005","journal-title":"Contraception"},{"key":"R31-8-20210129","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"R32-8-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"R33-8-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0950-3552(96)80064-2","article-title":"New hormonal methods of contraception","volume":"10","author":"Newton","year":"1996","journal-title":"Bailli\u00e8res Clin Obstet Gynecol"},{"key":"R34-8-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/humupd\/dmg004","article-title":"Implantable contraceptives for women","volume":"9","author":"Meirik","year":"2003","journal-title":"Human Reprod Update"},{"key":"R35-8-20210129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0889-8545(05)70172-8","article-title":"Implantable contraception","volume":"27","author":"Meckstroth","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R36-8-20210129","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-199855060-00019","article-title":"Levonorgestrel subdermal implants: a review of contraceptive efficacy and acceptability","volume":"55","author":"Coukell","year":"1988","journal-title":"Drugs"},{"key":"R38-8-20210129","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/humrep\/14.4.976","article-title":"A multicenter efficacy and safety study of a single contraceptive implant Implanon\u00ae","volume":"14","author":"Croxatto","year":"1999","journal-title":"Human Reprod"},{"key":"R39-8-20210129","first-page":"43","article-title":"Mirena\u00ae: the levonorgestrel intrauterine system (20 \u03bcg\/day)","volume":"1","author":"French","year":"2003","journal-title":"J Drug Eval"},{"key":"R40-8-20210129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol"},{"key":"R41-8-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(16)47540-0","article-title":"Ovarian function in amenorreic and menstruating users of levonorgestrel releasing intrauterine device","volume":"41","author":"Nilsson","year":"1984","journal-title":"Fert Steril"},{"key":"R42-8-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(90)90092-A","article-title":"Ovarian function during use of a levonorgestrel-releasing IUD","volume":"42","author":"Barbosa","year":"1990","journal-title":"Contraception"},{"key":"R43-8-20210129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"R44-8-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajog.2003.07.021","article-title":"Pregnancy during use of levonorgestrel intrauterine system","volume":"190","author":"Backman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R45-8-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1471-0528.2000.tb13228.x","article-title":"Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users","volume":"107","author":"Backman","year":"2000","journal-title":"BJOG"},{"key":"R46-8-20210129","first-page":"105","article-title":"Microdose intravaginal levonorgestrel contraception: a multicenter clinical trial. I: Contraceptive efficacy and side effects. II: Expulsions and removals. III: The relation between pregnancy rate and body weight. IV: Bleeding patterns.","volume":"41","year":"1990","journal-title":"Contraception"},{"key":"R47-8-20210129","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003081-200103000-00014","article-title":"Vaginal ring hormone delivery systems in contraception and menopause","volume":"44","author":"Ballagh","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"R48-8-20210129","first-page":"428","article-title":"Task Force of Postovulatory Methods of Fertility Regulation.","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R49-8-20210129","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(02)11767-3","article-title":"Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial","volume":"360","author":"von Hertzen","year":"2002","journal-title":"Lancet"},{"key":"R50-8-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13625180701330480","article-title":"Emergency contraception in Cuba with 10 mg of mifepristone","volume":"12","author":"Esteve","year":"2007","journal-title":"Eur J Contracept Reprod Healthcare"},{"key":"R51-8-20210129","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0039-128X(03)00140-5","article-title":"Nestorone: clinical applications for contraception and HRT","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Steroids"},{"key":"R52-8-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.contraception.2006.08.013","article-title":"Weekly contraception with mifepristone","volume":"75","author":"Pei","year":"2007","journal-title":"Contraception"}],"container-title":["Current Opinion in Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GCO.0b013e3282f1e7b6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:40:50Z","timestamp":1786038050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-200712000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e3282f1e7b6","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}